New HPV vaccine shows promise in protecting young girls and women
NCT ID NCT06632912
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental HPV vaccine in 1,800 females aged 9 to 35. The goal is to see if giving two doses to girls aged 9-14 works as well as three doses in older girls and women. Participants receive the vaccine in their upper arm and have several visits to check their immune response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Daiyue District Center for Disease Control and Prevention
Tai’an, Shandong, China
-
Liaocheng Center for Disease Control and Prevention
Liaocheng, Shandong, China
-
Shanxian Center for Disease Control and Prevention
Heze, Shandong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Period blood may offer a needle-free HPV test — a trial puts it to the test
- Vaccine trains immune system to fight HPV-Positive head and neck tumors
- HPV knowledge showdown: digital quiz vs. escape room
- New combo aims to tame HPV throat cancer with fewer side effects
- HPV education showdown: video vs. Face-to-Face to boost vaccine uptake
- Could less radiation be just as effective for HPV throat cancer?